| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Royalty Pharma plc | Director | Class A Ordinary Shares | 81.4K | $2.6M | $31.95 | May 13, 2025 | Direct |
| Royalty Pharma plc | Director | Class A Ordinary Shares | 73.7K | $2.23M | $30.23 | Jun 7, 2024 | Direct |
| Cyclerion Therapeutics, Inc. | Director | Common Stock | 30K | $102K | $3.40 | Nov 30, 2023 | Direct |
| Alector, Inc. | Director | Common Stock | 70K | $81.1K | $1.16 | Jun 11, 2025 | Direct |
| CATALYST BIOSCIENCES, INC. | Director | Common Stock | 29.8K | $14K | $0.47 | Oct 1, 2021 | Direct |
| CATALYST BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 14K | Jun 9, 2021 | Direct | ||
| Alector, Inc. | Director | Stock Option (right to buy) | 9.45K | Jun 11, 2025 | Direct |